Methods: A total of 72 male Wistar-Albino rats were randomly divided into three equal groups. To induce a rib fracture, right thoracotomy was performed under general anesthesia and a 0.5-cm segment was removed from the fourth and fifth ribs. After 24 h of surgery, low-intensity pulsed ultrasound was implemented according to the groups. Group 1 served as the control group for the observation of normal bone healing. Low-intensity pulsed ultrasound was applied at a dose of 20% (2 msn pulse-8 msn pause) 100 mW/cm2 and 50% (5 msn pulse-5 msn pause) 200 mW/cm2 for six min, respectively in Group 2 and Group 3. All subjects were followed for six weeks. Eight animals from each group were sacrificed at two, four, and six weeks for further assessment. Histological alterations in the bone were examined.
Results: Although there was no statistically significant difference in osteoblasts, osteoclasts, new bone formation, and lymphocyte count among the groups, histological consolidation was significantly increased by low-intensity pulsed ultrasound. While low-intensity pulsed ultrasound induced osteoblastic, osteoclastic, and new bone formation, it inhibited lymphocyte infiltration.
Conclusion: Low-intensity pulsed ultrasound, either at low or high doses, induced the histological consolidation of rib fractures and inhibited lymphocyte infiltration. This effect was more prominent in the long-term and at higher dose with increased daily and total administration time. We, therefore, believe that accelerating the natural healing process in patients with rib fractures would enable to treat more effectively in short-term.
The sound is a linearly propagating mechanical wave in the material environment. A total of 20 to 20,000 Hz frequencies can be heard by the human ear. The sound waves under this frequency are called infrasound and above are called ultrasound (US), the name given to the higher frequency sound waves that the human ear cannot hear.[9,10] While US is commonly used for imaging purposes, low-intensity pulsed ultrasound (LIPUS) has been used in physiotherapy for the treatment of pain, musculoskeletal system injuries, and soft tissue lesions for about six decades.[11]
Rib fractures may be painful and potentially injurious. In chest traumas, particularly in RFs, mortality and morbidity can be reduced with the control of pain. Pain is reduced by the provision of bone stabilization.[12] In the literature, LIPUS has been shown to increase osteogenesis in animal models.[13] In the present study, we hypothesized that LIPUS would accelerate RB healing and aimed to investigate the effects of LIPUS on RF healing in a rat model.
a) Study groups
The subjects were divided into three equal groups
including 24 (n=24) male rats in each group. Prior to
the operation, the rats were numbered separately by
drawing a line on their tails, and their weights (g) were
measured and recorded. To induce the experimental
RF model, a 0.5-cm rib was removed from the fourth
and fifth ribs of the right hemithorax. Group 1 served
as the control group and the course of natural healing
was followed. Group 2 and Group 3 were administered
LIPUS.
b) Application of LIPUS
The application of LIPUS with BTL-4000 Sono
(BTL Hertfordshire, UK) (Figure 1) pulse US was
initiated 24 h after the operation. Each subject
underwent daily LIPUS administration at a frequency
of 1 MHz daily under general anesthesia following
manual restriction. A total of 20% of Group 2 received
100 mW/cm2 (2 msec pulse-8 msec pause) and 50% of
Group 3 received 200 mW/cm2 (5 msec pulse-5 msec
pause). Low-intensity pulse ultrasound was applied to each animal for six min at a single session daily
between 09:00 AM and 05:00 PM for a total of six
consecutive weeks.
Figure 1: A photograph of BTL-4000 Sono (BTL, Hertfordshire, UK).
c) Anesthesia protocol
Induction was provided with ketamine
hydrochloride (Ketanest, Pfizer Pharma GmbH,
Karlsruhe, Germany) with 15 to 20 mg/kg intravenous
(IV) or 20 to 25 mg/kg intramuscular (IM). General
anesthesia with xylazine (Rampun®, 2% 50 cc Bayer
Türk İlaç A.Ş., Istanbul, Turkey) at a dose of 0.5
to 1 mg/kg IV or 1 to 2 mg/kg IM, and anesthesia
was maintained with the same doses. The mean
duration of anesthesia was 10 to 15 min for each
rat. The subjects were administrated 50 mg/kg IM
of ceftazidime pentahydrate twice daily (Fortum®,
GlaxoSmithKline Inc., Brentford, UK) for five days
for prophylaxis.
d) Operation technique
After proper field cleaning and antisepsis for the
rats under general anesthesia, a lateral thoracotomy
incision was performed through the right fifth lateral
intercostal space while lying on the left side position.
The muscles were dissected, and the chest wall was
reached. The rats underwent double subperiosteal half
(0.5)-cm costal resection starting from the fourth rib
in the right hemithorax. The layers were closed with
continuous sutures from the muscles according to the
procedure. Pneumothorax control of each subject was
performed after the operation.
e) Postoperative care and follow-up
Tramadol hydrochloride (Contramal, 100 mg
2 mL, Abdi Ibrahim İlaç Sanayi ve Tic. A.Ş., Istanbul,
Turkey) at a dose of 1 to 2 mg/kg IM was used for five
days to control pain in the postoperative period. A total
of 24 subjects including eight from each group were
euthanized with a lethal IV dose of non-barbiturate
anesthetic (ketamine/xylazine) painlessly according to
the existing instructions established by the latest report
of the American Veterinary Medical Association Panel
on Euthanasia.[14] For three times, the anesthetic dose
was used for euthanasia at two, four, and six weeks
after surgery. The total follow-up was six weeks.
f) Pathological examination
All materials were decalcified in 10% buffered
formaldehyde for 48 h after the fixation period, until
they were tempered enough to be cut with a microtome.
Tissue specimens from appropriate sites were, then,
taken for the Autotecnicon (Autotecnicon-Shandon,
Cheshire, UK) follow-up, embedded in paraffin,
stained with hematoxylin-eosin (H-E), and sectioned with a microtome to calculate the osteoclast, osteoblast,
lymphocyte count, and the area of new bone formation
(Figure 2). All stained preparations were examined
with Nikon Eclipse E400 light microscope (Nikon
Corp., Minato-ku, Tokyo, Japan). Care was given
to select as possible as the same areas for each case
during the assessment. The selected areas were scanned
with a Nikon Coolpix 5000 digital camera (Nikon
Corp., Minato-ku, Tokyo, Japan) with a microscope
mounted at the same microscope magnification. At the
same time, the Nikon Stage Micrometer (MBM11100,
Nikon Corp., Minato-ku, Tokyo, Japan) images were
also taken for calibration with the same microscope
magnification. All images were transferred to a PC
environment for analysis using the Clemex Vision Lite
3.5 (Clemex Technologies Inc., Longueuil, Quebec,
Canada) (Figure 3). First, the length was calibrated
with the Nikon Stage Micrometer (MBM11100,
Nikon Corp., Minato-ku, Tokyo, Japan). After the
calibration, the area to be examined was determined
as 38732.7 µm2. The osteoblasts, osteoclasts, and
lymphocytes on the 38,732.7 µm2 areas selected on the
digital images of H-E stained preparations were marked
and automatically counted by the aforementioned
image analysis program. The damaged cells were
excluded from the analysis.
Statistical analysis
Statistical analysis was performed using the PASW
version 18.0 software (SPSS Inc., Chicago, IL, USA).
Descriptive data were expressed in mean ± standard
deviation or number and frequency. The Kruskal-
Wallis and Mann-Whitney U test were used to analyze
significant differences among the groups. A p value of
<0.05 was considered statistically significant.
Osteoblast, osteoclast, and new bone formation were not detected in all groups at the end of the second week. However, lymphocytes from inflammatory cells were higher in LIPUS groups.
Osteoblast, osteoclast, and new bone formation were not detected in the control group during the fourth week. However, osteoblast, osteoclast, and new bone formation were higher in LIPUS groups compared to the control group. Group 2 stimulated osteoblasts more than group 3. However, new bone formation was higher in group 3. Although lymphocytes decreased in all groups; In the LIPUS groups, this reduction was proportionally higher.
In the sixth week, osteoblast osteoclast and new bone formation were encountered for the first time in the control group. Osteoblast, osteoclast, and new bone formation were higher in the LIPUS groups compared to the control group. The opposite situation was also observed in lymphocytes. However, histological consolidation was significantly increased by LIPUS at any dose. This effect was more long-lasting and pronounced at higher doses (Table 1).
Table 1: A comparison of parameters analyzed among the rat groups
Chest pain, which is the most common symptom of RFs, arises from broken bones, damaged soft tissues, and muscles. It is usually exacerbated by movements of the chest wall, including deep breathing and coughing, even in normal breathing movements.[6] Traditionally, the treatment of RFs is symptomatic based on the control of pain, which is provided with analgesics including narcotic and non-steroidal anti-inflammatory drugs, respiratory physiotherapy, and specific treatment approaches of related complications. Despite all treatment options, 31% of cases experience complications such as nosocomial pneumonia, prolonged respiratory failure, long-term hospitalization, or death due to advanced age, and accompanying comorbid diseases and traumas.[6,8,18] Although the number of RFs and the age of the patient are designated as the factors which increase mortality and morbidity in the literature, this issue is still controversial.[15] While high morbidity is defined in patients older than 65 years, a similar high mortality and morbidity tendency has been described in younger patients, as well.[19] The number of RFs is similar. Whitson et al.[20] showed that high mortality and morbidity rates were not associated with the number of RFs in a total of 35,467 study cohort. However, the authors were unable to assess whether RFs worsened or exacerbated existing comorbidities or had any effect on the severity of accompanying injuries. On the other hand, Jones et al.[16] identified five and more RFs as independent causes of mortality in a total of 98,836 patients. Mortality and morbidity are reduced with the control of pain in chest traumas, particularly in RFs and reduced by the provision of pain and bone stability.[12]
The biological effects of the US were first noticed
in 1917.[9] It is used for the treatment of pain,
traumatic musculoskeletal traumas, and soft tissue
lesions. The US, which is acoustic radiation, is a
form of mechanical energy which can be transmitted
into the body as a high-frequency pressure wave.[21]
This energy can be divided into two categories: highintensity
(5,000 to 15,000 W/cm2) and low-intensity
(0.5 to 3,000 mW/cm2). Low-intensity US is used in
physiotherapy and have micro-massage effect on the
interstitial fluid movement in tissues. This effect is
utilized in edematous tissues, and wound healing
is accelerated. Intracellular calcium concentration
increases the cell membrane permeability, mast cell
degranulation, chemotactic factor and histamine
release, macrophage response, and protein synthesis
from fibroblasts. Ultrasound is known as a modality
which accelerates tissue healing, as cellular events are
indispensable components of tissue healing.[22,23] The
healing effect of US on bones and soft tissue is wellknown
and widely used.[24]
The factors which increase bone healing have
been extensively researched in the literature in the
last six decades. It has been shown extensively in
animal experiments that US which is widely used in
diagnosis and treatment augments osteogenesis. In
these experiments, extreme fractures such as radius
and femur bones have been studied.[13,18,21,22,24] In
the literature, there is only one study investigating
the treatment of RFs with US.[17] In this study,
the subjects were divided into three groups of
10% (50 mW/cm2), 20% (100 mW/cm2), and 50%
(250 mW/cm2) and LIPUS was applied for three
minutes daily for 28 days. Finally, 50 mW/cm2 was
determined as the most effective dose available. In
our study, we determined the application period as
six min which was 15 to 20 min in the literature
for lower extremity fractures. As we aimed to
investigate the effects of LIPUS on RFs in the longer
application, daily application time was six min, rather than three min and the total period was
six weeks, rather than four weeks in our study. In
the first two weeks, no osteoblast, osteoclast, and
new bone formation were detected. However, at
four weeks, osteoblast, osteoclast, and new bone
formation were detected, and bone formation was
more evident in the LIPUS-treated groups. The
results were similar at six weeks (Table 1). We also
found that osteoblasts were similarly affected by
new bone formation; however, at four weeks, the
osteoblast count was 20% (100 mW/cm2) higher in
the LIPUS group. This finding is consistent with the
findings of Santana-Rodríguez et al.[18]
Nonetheless, there are some limitations to this
study. First, we studied only major ribs or bones,
although soft tissue is worth investigating in further
studies. Second, we found no significant difference
among the groups in terms of the osteoblast, osteoclast,
new bone formation, and lymphocyte infiltration.
Third, as an experimental animal study, our study
might have yielded different results in human tissues.
Therefore, these findings should be clarified with
further experimental and clinical studies. Finally,
further large-scale, long-term studies are needed to
gain a better understanding of the effects of LIPUS on
RF healing.
In conclusion, rib fractures are painful and can be
potentially disabling. This may result in social and
economic costs, both to the national healthcare system
and to individuals in the form of lost productivity
and impaired quality of life. Any improvements of
its treatment would have evenly great benefit on not
only on individual, but also on society. Clinical and
experimental investigations have demonstrated that
low-intensity pulse ultrasound is effective for bone
metabolism and new bone development. Histological
examination has shown that osteoblast, osteoclast,
chondrocyte, and mesenchymal stem cells are
responsible for new bone development and healing.
In accordance with the literature, although there was
no significant difference among the groups in terms
of osteoblast, osteoclast, new bone formation, and
lymphocyte infiltration, histological consolidation
was significantly increased and lymphocyte
infiltration decreased in the rat groups treated with
low-intensity pulse ultrasound. This effect was more
prominent in the long-term and at higher doses
with increased daily and total administration time.
We, therefore, believe that accelerating the natural
healing process in patients with rib fractures would
enable to treat more effectively in short-term.
Declaration of conflicting interests
Funding
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
The authors received no financial support for the research
and/or authorship of this article.
1) Altunkaya A, Aktunc E, Kutluk AC, Buyukates M, Demircan
N, Demir AS, et al. Analysis of 282 patients with thoracic
trauma. Turk J Thorac Cardiovasc Surg 2007;15:127-32.
2) Meredith JW, Hoth JJ. Thoracic trauma: when and how to
intervene. Surg Clin North Am 2007;87:95-118.
3) Sharma OP, Oswanski MF, Jolly S, Lauer SK, Dressel
R, Stombaugh HA. Perils of rib fractures. Am Surg
2008;74:310-4.
4) Doben AR, Eriksson EA, Denlinger CE, Leon SM, Couillard
DJ, Fakhry SM, et al. Surgical rib fixation for flail chest
deformity improves liberation from mechanical ventilation. J
Crit Care 2014;29:139-43.
5) Fabricant L, Ham B, Mullins R, Mayberry J. Prolonged pain
and disability are common after rib fractures. Am J Surg
2013;205:511-5.
6) Kerr-Valentic MA, Arthur M, Mullins RJ, Pearson TE,
Mayberry JC. Rib fracture pain and disability: can we do
better? J Trauma 2003;54:1058-63.
7) Majercik S, Cannon Q, Granger SR, VanBoerum DH, White
TW. Long-term patient outcomes after surgical stabilization
of rib fractures. Am J Surg 2014;208:88-92.
8) Bhatnagar A, Mayberry J, Nirula R. Rib fracture fixation
for flail chest: what is the benefit? J Am Coll Surg
2012;215:201-5.
9) Basford JR. Physical Agents. In: DeLisa JA, Gans Bm,
editors. Rehabilitation Medicine Principles and Practice.
3rd ed. Philadelphia: Lippincott-Raven Publishers; 1998.
p. 488-99.
10) Tuncer T. Elektroterapi. Fiziksel Tıp ve Rehabilitasyon.
Editörler: Beyazova M, Gökçe Kutsal Y. Cilt 2. Ankara:
Güneş Kitabevi; 2000. s. 771-89.
11) Warden SJ. A new direction for ultrasound therapy in sports
medicine. Sports Med 2003;33:95-107.
12) Easter A. Management of patients with multiple rib fractures.
Am J Crit Care 2001;10:320-7.
13) Takikawa S, Matsui N, Kokubu T, Tsunoda M, Fujioka H,
Mizuno K, et al. Low-intensity pulsed ultrasound initiates
bone healing in rat nonunion fracture model. J Ultrasound
Med 2001;20:197-205.
14) Leary SL, Underwood W, Anthony R, Gwaltney-Brant
S, Poison A, Meyer R, et al. AVMA guidelines for the
euthanasia of animals: 2013 edition. Schaumburg IL:
American Veterinary Medical Association; 2013.
15) Boris K, Forat S, Itamar A, Oded O, Kobi P, Adi G, et al.
Increasing number of fractured ribs is not predictive of
the severity of splenic injury following blunt trauma: an
analysis of a National Trauma Registry database. Injury
2014;45:855-8.
16) Jones KM, Reed RL, Luchette FA. The ribs or not the ribs:
which influences mortality? Am J Surg 2011;202:598-604.
17) Flagel BT, Luchette FA, Reed RL, Esposito TJ, Davis KA,
Santaniello JM, et al. Half-a-dozen ribs: the breakpoint for
mortality. Surgery 2005;138:717-23.
18) Santana-Rodríguez N, Clavo B, Fernández-Pérez L, Rivero
JC, Travieso MM, Fiuza MD, et al. Pulsed ultrasounds
accelerate healing of rib fractures in an experimental
animal model: an effective new thoracic therapy? J Thorac
Cardiovasc Surg 2011;141:1253-8
19) Holcomb JB, McMullin NR, Kozar RA, Lygas MH, Moore
FA. Morbidity from rib fractures increases after age 45. J Am
Coll Surg 2003;196:549-55.
20) Whitson BA, McGonigal MD, Anderson CP, Dries DJ.
Increasing numbers of rib fractures do not worsen outcome:
an analysis of the national trauma data bank. Am Surg
2013;79:140-50.
21) Speed CA. Therapeutic ultrasound in soft tissue lesions.
Rheumatology (Oxford) 2001;40:1331-6.
22) Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev
Biomed Eng 2004;6:229-48.